Author:
Devonshire Alison S.,O’Sullivan Denise M.,Honeyborne Isobella,Jones Gerwyn,Karczmarczyk Maria,Pavšič Jernej,Gutteridge Alice,Milavec Mojca,Mendoza Pablo,Schimmel Heinz,Van Heuverswyn Fran,Gorton Rebecca,Cirillo Daniela Maria,Borroni Emanuele,Harris Kathryn,Barnard Marinus,Heydenrych Anthenette,Ndusilo Norah,Wallis Carole L.,Pillay Keshree,Barry Thomas,Reddington Kate,Richter Elvira,Mozioğlu Erkan,Akyürek Sema,Yalçınkaya Burhanettin,Akgoz Muslum,Žel Jana,Foy Carole A.,McHugh Timothy D.,Huggett Jim F.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Huggett JF, McHugh TD, Zumla A. Tuberculosis: amplification-based clinical diagnostic techniques. Int J Biochem Cell Biol. 2003;35(10):1407–12.
2. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005–15.
3. World Health Organization: Policy Statement: Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Geneva; 2011.
4. TB Xpert project - rolling out innovative MDR-TB Diagnostics [ http://www.unitaid.eu/en/mdr-tb-diagnostics ]. Accessed 27th Jan 2016.
5. Public Health England: Position statement: Direct molecular testing for tuberculosis in England, Scotland and Wales; 2013.